Preterm Births and PROM Testing Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Test Type ; By End User ; By End Use ; By Region

Description

Global Preterm Births and PROM Testing Market Size Set to Cross USD 362 Million by 2029.

Global preterm births and PROM testing market is flourishing because of increasing awareness about and technological advancements in point-of care and PROM testing for the management of preterm and low-weight births.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global preterm births and PROM testing market size at USD 198.54 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global preterm births and PROM testing market size to grow at a significant CAGR of 7.74% reaching a value of USD 362.41 million by 2029. Major growth factors of global preterm births and PROM testing market include increasing incidence of preterm and low-weight births worldwide, rapid continuous development of point-of-care diagnostic techniques and growing technological advancements in PROM testing equipment. Greater awareness of the availability of testing for preterm births and PROM is also a significant driver. Also, the market growth is driven by the rise in premature births and associated child mortality rates. People are increasingly seeking testing services at diagnostic labs and healthcare facilities, particularly in emerging regions. Diagnostic centers are becoming increasingly popular due to their reliability, affordability, rapid results, and accurate diagnosis, making them a preferred choice. As a result, the market is expected to grow significantly in the coming years. However, lack of awareness and economic constraints in under-developed countries is anticipated to restrain the growth of overall market.

Global Preterm Births and PROM Testing Market - Overview:

Premature Rupture of Membrane, commonly known as PROM, is a prevalent complication in pregnancy and a significant cause of preterm births. Preterm birth testing and PROM testing encompass the examination of symptoms, such as vaginal spotting, cramps, contractions, pelvic pressure, vaginal discharge, and fluid leakage, by gynecologists to identify preterm labor. Expectant management and hospitalization are some of the management and treatment strategies for PROM. In rare cases, the membrane may self-seal without intervention, stopping fluid leakage. To determine changes in the cervix and record contractions, healthcare professionals frequently perform pelvic exams over a few hours. Traditional techniques, such as fetal fibronectin (fFN) test, pelvic examination, blood test, ultrasound, and sterile speculum inspection (pooling), are highly accurate in detecting preterm labor. Timely detection of preterm labor reduces the risk of infant morbidity and mortality, decreases the hospital stay for high-risk patients, and eliminates unnecessary medical expenses.

Impact of COVID-19 on Global Preterm Births and PROM Testing Market

COVID-19 had a detrimental impact on the global preterm birth and PROM testing market. The pandemic resulted in the redirection of healthcare resources and attention towards COVID-19, potentially leading to a decline in preterm birth and PROM testing. The global economic downturn caused by the pandemic may also result in reduced healthcare spending, which could further impact the market's growth. Moreover, the pandemic has led to disruptions in supply chains and manufacturing operations, which may cause delays in the production and delivery of diagnostic equipment and testing supplies. However, the increasing focus on public health and the importance of early detection of diseases may provide opportunities for the market to rebound in the post-pandemic period. In response to the pandemic, healthcare facilities and diagnostic labs have implemented new safety protocols to reduce the risk of transmission, including the use of telemedicine and remote testing options. These adaptations may help to maintain access to preterm birth and PROM testing while reducing the risk of exposure to COVID-19.

Global Preterm Births and PROM Testing Market - By End User:

Based on end user, global preterm births and PROM testing market is bifurcated into Hospitals and Clinical Laboratories segments. The clinical laboratories segment holds a higher share in the global preterm births and PROM testing market due to the increasing demand for accurate and reliable diagnostic testing and clinical laboratories offer a wide range of diagnostic tests and services for preterm births and PROM testing, including fetal fibronectin (fFN) testing, pelvic examination, blood tests, and sterile speculum inspection (pooling). Also, clinical laboratories provide fast and efficient testing services, allowing for timely diagnosis and treatment, thereby reducing the risk of preterm births and improving neonatal outcomes coupled with the increasing prevalence of preterm births and associated complications worldwide is boosting the demand for clinical laboratory services for preterm births and PROM testing.

Competitive Landscape:

Major players operating global preterm births and PROM testing market include: Hologic, Inc, Abbott, Sera Prognostics Inc., Cooper Surgical Inc., IQ Products, Qiagen N.V., Biosynex, LifeCell International Pvt. Ltd., Clinical Innovations, Inc., NX Prenatal, Inc., Medixibiochemica, Medtronic, Fisher & Paykel Healthcare Limited, FUJIFILM Holdings Corporation, Nonin, Getinge AB, General Electric, and Koninklijke Philips N.V. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Preterm Births and PROM Testing Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Preterm Births and PROM Testing Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC23307

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Preterm Births and PROM Testing Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Growing Incidence of Preterm and Low-weight Births
  - 3.2.1.2. Rising Awareness and Technological Advancements in Point-Of Care and PROM Testing
- 3.2.2. Restraints
  - 3.2.2.1. Lack of Awareness and Economic Constraints in Under-developed Countries
- 3.2.3. Opportunities
  - 3.2.3.1. Advancements in Technology
- 3.2.4. Challenges
  - 3.2.4.1. High cost and unmet needs
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Global Preterm Births and PROM Testing Market Overview

4.1. Market Size & Forecast, 2019-2029
- 4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
- 4.2.1. By Test Type
  - 4.2.1.1. Pelvic Exam
  - 4.2.1.2. Ultrasound
  - 4.2.1.3. Biochemical Markers
  - 4.2.1.4. Uterine Monitoring
  - 4.2.1.5. Nitazine Test
  - 4.2.1.6. Ferning Test
  - 4.2.1.7. Pooling
- 4.2.2. By End User
  - 4.2.2.1. Hospitals
  - 4.2.2.2. Clinical Laboratories
  - 4.2.2.3. Others
- 4.2.3. By Region
  - 4.2.3.1. North America
  - 4.2.3.2. Europe
  - 4.2.3.3. Asia Pacific (APAC)
  - 4.2.3.4. Latin America (LATAM)
  - 4.2.3.5. Middle East and Africa (MEA)

5. North America Preterm Births and PROM Testing Market

5.1. Market Size & Forecast, 2019-2029
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Test Type
- 5.2.2. By End User
- 5.2.3. By Country
  - 5.2.3.1. United States
  - 5.2.3.1.1. By Test Type
  - 5.2.3.1.2. By End User
  - 5.2.3.2. Canada
  - 5.2.3.2.1. By Test Type
  - 5.2.3.2.2. By End User

6. Europe Preterm Births and PROM Testing Market

6.1. Market Size & Forecast, 2019-2029
- 6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
- 6.2.1. By Test Type
- 6.2.2. By End User
- 6.2.3. By Country
  - 6.2.3.1. Germany
  - 6.2.3.1.1. By Test Type
  - 6.2.3.1.2. By End User
  - 6.2.3.2. United Kingdom
  - 6.2.3.2.1. By Test Type
  - 6.2.3.2.2. By End User
  - 6.2.3.3. Italy
  - 6.2.3.3.1. By Test Type
  - 6.2.3.3.2. By End User
  - 6.2.3.4. France
  - 6.2.3.4.1. By Test Type
  - 6.2.3.4.2. By End User
  - 6.2.3.5. Spain
  - 6.2.3.5.1. By Test Type
  - 6.2.3.5.2. By End User
  - 6.2.3.6. Belgium
  - 6.2.3.6.1. By Test Type
  - 6.2.3.6.2. By End User
  - 6.2.3.7. Russia
  - 6.2.3.7.1. By Test Type
  - 6.2.3.7.2. By End User
  - 6.2.3.7.3.
  - 6.2.3.8. The Netherlands
  - 6.2.3.8.1. By Test Type
  - 6.2.3.8.2. By End User
  - 6.2.3.9. Rest of Europe
  - 6.2.3.9.1. By Test Type
  - 6.2.3.9.2. By End User

7. Asia-Pacific Preterm Births and PROM Testing Market

7.1. Market Size & Forecast, 2019-2029
- 7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
- 7.2.1. By Test Type
- 7.2.2. By End User
- 7.2.3. By Country
  - 7.2.3.1. China
  - 7.2.3.1.1. By Test Type
  - 7.2.3.1.2. By End User
  - 7.2.3.2. India
  - 7.2.3.2.1. By Test Type
  - 7.2.3.2.2. By End User
  - 7.2.3.3. Japan
  - 7.2.3.3.1. By Test Type
  - 7.2.3.3.2. By End User
  - 7.2.3.4. South Korea
  - 7.2.3.4.1. By Test Type
  - 7.2.3.4.2. By End User
  - 7.2.3.5. Australia & New Zealand
  - 7.2.3.5.1. By Test Type
  - 7.2.3.5.2. By End User
  - 7.2.3.6. Indonesia
  - 7.2.3.6.1. By Test Type
  - 7.2.3.6.2. By End User
  - 7.2.3.7. Malaysia
  - 7.2.3.7.1. By Test Type
  - 7.2.3.7.2. By End User
  - 7.2.3.8. Singapore
  - 7.2.3.8.1. By Test Type
  - 7.2.3.8.2. By End User
  - 7.2.3.9. Vietnam
  - 7.2.3.9.1. By Test Type
  - 7.2.3.9.2. By End User
  - 7.2.3.10. Rest of APAC
  - 7.2.3.10.1. By Test Type
  - 7.2.3.10.2. By End User

8. Latin America Preterm Births and PROM Testing Market

8.1. Market Size & Forecast, 2019-2029
- 8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
- 8.2.1. By Test Type
- 8.2.2. By End User
- 8.2.3. By Country
  - 8.2.3.1. Brazil
  - 8.2.3.1.1. By Test Type
  - 8.2.3.1.2. By End User
  - 8.2.3.2. Mexico
  - 8.2.3.2.1. By Test Type
  - 8.2.3.2.2. By End User
  - 8.2.3.3. Argentina
  - 8.2.3.3.1. By Test Type
  - 8.2.3.3.2. By End User
  - 8.2.3.4. Peru
  - 8.2.3.4.1. By Test Type
  - 8.2.3.4.2. By End User
  - 8.2.3.5. Rest of LATAM
  - 8.2.3.5.1. By Test Type
  - 8.2.3.5.2. By End User

9. Middle East & Africa Preterm Births and PROM Testing Market

9.1. Market Size & Forecast, 2019-2029
- 9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
- 9.2.1. By Test Type
- 9.2.2. By End User
- 9.2.3. By Country
  - 9.2.3.1. Saudi Arabia
  - 9.2.3.1.1. By Test Type
  - 9.2.3.1.2. By End User
  - 9.2.3.2. UAE
  - 9.2.3.2.1. By Test Type
  - 9.2.3.2.2. By End User
  - 9.2.3.3. Qatar
  - 9.2.3.3.1. By Test Type
  - 9.2.3.3.2. By End User
  - 9.2.3.4. Kuwait
  - 9.2.3.4.1. By Test Type
  - 9.2.3.4.2. By End User
  - 9.2.3.5. South Africa
  - 9.2.3.5.1. By Test Type
  - 9.2.3.5.2. By End User
  - 9.2.3.6. Nigeria
  - 9.2.3.6.1. By Test Type
  - 9.2.3.6.2. By End User
  - 9.2.3.7. Algeria
  - 9.2.3.7.1. By Test Type
  - 9.2.3.7.2. By End User
  - 9.2.3.8. Rest of MEA
  - 9.2.3.8.1. By Test Type
  - 9.2.3.8.2. By End User

10. Competitive Landscape

10.1. List of Key Players and Their Offerings
10.2. Global Preterm Births and PROM Testing Company Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Preterm Births and PROM Testing Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

12.1. Hologic, Inc
12.2. Abbott
12.3. Sera Prognostics Inc.
12.4. Cooper Surgical Inc.
12.5. IQ Products
12.6. Qiagen N.V.
12.7. Biosynex
12.8. LifeCell International Pvt. Ltd.
12.9. Clinical Innovations, Inc.
12.10. NX Prenatal, Inc.
12.11. Medixibiochemica
12.12. Medtronic
12.13. Fisher & Paykel Healthcare Limited
12.14. FUJIFILM Holdings Corporation
12.15. Nonin
12.16. Getinge AB
12.17. General Electric
12.18. Koninklijke Philips N.V.
12.19. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research?
- 14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations